PackGene to Highlight AI-Driven Gene Therapy Innovations at ASGCT 2025

PackGene to Highlight AI-Driven Gene Therapy Innovations at ASGCT 2025

PackGene Biotech, Inc. will present its latest advancements in scalable AAV manufacturing and AI-driven capsid engineering at the ASGCT 2025 meeting in New Orleans, according to a press release.

PackGene Biotech, Inc. will showcase its latest advancements in scalable AAV manufacturing and AI-driven capsid engineering at the American Society of Gene & Cell Therapy (ASGCT) 28th annual meeting in New Orleans from May 13-17, 2025. In a press release, the company announced six presentations highlighting its comprehensive suite of technology platforms and CDMO solutions aimed at accelerating gene therapy development and reducing costs.

Key presentations include a forum on advancing AAV manufacturing for affordable gene therapy and a poster session on targeted gene therapy using PackGene's π-Icosa Platform. The company will also discuss innovations in AAV production efficiency and capsid quantification, which are crucial for improving gene therapy affordability and effectiveness.

PackGene's integrated approach includes AI-assisted AAV capsid engineering, high-productivity vector manufacturing, and robust process analytics tools. These innovations are designed to address industry challenges such as vector tissue targeting, immunogenicity, safety, and manufacturability, supporting the company's mission to make gene therapy more accessible.

We hope you enjoyed this article.

Consider subscribing to one of several newsletters we publish. For example, in the Daily AI Brief you can read the most up to date AI news round-up 6 days per week.

Also, consider following us on social media:

AI Brief
AI Brief (X)

More from: Healthcare & Life Sciences

Subscribe to Daily AI Brief

Daily report covering major AI developments and industry news, with both top stories and complete market updates

Sponsored

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like